TRxADE HEALTH (NASDAQ:MEDS) Stock Price Down 5.4% – Time to Sell?

TRxADE HEALTH, Inc. (NASDAQ:MEDS) traded down 5.4% on Tuesday . The company traded as low as $7.10 and last traded at $7.23. 11,922 shares changed hands during trading, a decline of 94% from the average session volume of 207,831 shares. The stock had previously closed at $7.64.

TRxADE HEALTH Trading Down 5.4 %

The business’s 50 day moving average is $7.51 and its two-hundred day moving average is $8.74.

Institutional Investors Weigh In On TRxADE HEALTH

An institutional investor recently bought a new position in TRxADE HEALTH stock. Virtu Financial LLC purchased a new position in TRxADE HEALTH, Inc. (NASDAQ:MEDS) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 10,617 shares of the company’s stock, valued at approximately $109,000. Virtu Financial LLC owned approximately 0.75% of TRxADE HEALTH at the end of the most recent quarter. Hedge funds and other institutional investors own 5.68% of the company’s stock.

TRxADE HEALTH Company Profile

TRxADE HEALTH, Inc operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace.